H.P. Acthar Gel Interactions
There are 387 drugs known to interact with H.P. Acthar Gel (corticotropin), along with 20 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 322 are moderate, and 15 are minor.
- View all 387 medications that may interact with H.P. Acthar Gel
- View H.P. Acthar Gel alcohol/food interactions (1)
- View H.P. Acthar Gel disease interactions (20)
Most frequently checked interactions
View interaction reports for H.P. Acthar Gel (corticotropin) and the medicines listed below.
- albuterol
- allopurinol
- alprazolam
- amlodipine
- baclofen
- Calcium 600 D (calcium / vitamin d)
- Celebrex (celecoxib)
- doxycycline
- duloxetine
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxyzine
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- melatonin
- meloxicam
- metformin
- modafinil
- mycophenolate mofetil
- omeprazole
- prednisone
- Singulair (montelukast)
- tizanidine
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
H.P. Acthar Gel alcohol/food interactions
There is 1 alcohol/food interaction with H.P. Acthar Gel (corticotropin).
H.P. Acthar Gel disease interactions
There are 20 disease interactions with H.P. Acthar Gel (corticotropin) which include:
- (+) tuberculin test
- adrenal insufficiency
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticism
- infections
- ocular herpes simplex
- osteoporosis
- PUD
- scleroderma
- vaccination
- cirrhosis
- depression/psychoses
- diabetes
- elevated IOP
- hypothyroidism
- myasthenia gravis
- myopathy
- thromboembolism
Report options
More about H.P. Acthar Gel (corticotropin)
- H.P. Acthar Gel consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: corticotropin
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Montelukast
Montelukast is a daily oral medication used to prevent asthma attacks, exercise-induced ...
Diclofenac
Diclofenac is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation associated ...
Naproxen
Naproxen is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by ...
Fluticasone nasal
Fluticasone nasal is used for allergic rhinitis, allergies, chronic rhinosinusitis with nasal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.